Aims: To evaluate the utility of a multiparametric 3T magnetic resonance imaging (MRI) study using diffusion-weighted images (DWI) for the assessment of prostate cancer before and after radiotherapy (RT). Methods: A total of 34 patients, who received a histologic diagnosis of prostate adenocarcinoma, underwent MRI examination before and after local RT for the assessment of response to treatment. Apparent diffusion coefficient (ADC) values were calculated and compared. Results: Before RT, DWI shows pathologic restriction of signal, while after RT pathologic restriction of signal was reduced or disappeared. The ADC values were significantly increased after therapy (p<0.05). Conclusions: The use of DWI with ADC measurements may be an imaging biomarker in the assessment of prostate cancer.

Diffusion-weighted magnetic resonance imaging in patients with prostate cancer treated with radiotherapy / Iannelli, G.; Caivano, R.; Rago, L.; Simeon, V.; Lotumolo, A.; Rabasco, P.; Villonio, A.; Gioioso, M.; Mastrangelo, P.; Barchetti, F.; Panebianco, V.; Macarini, L.; Guglielmi, G.; Cammarota, A.. - In: TUMORI. - ISSN 0300-8916. - 102:1(2016), pp. 71-76. [10.5301/tj.5000415]

Diffusion-weighted magnetic resonance imaging in patients with prostate cancer treated with radiotherapy

Barchetti F.;Panebianco V.;
2016

Abstract

Aims: To evaluate the utility of a multiparametric 3T magnetic resonance imaging (MRI) study using diffusion-weighted images (DWI) for the assessment of prostate cancer before and after radiotherapy (RT). Methods: A total of 34 patients, who received a histologic diagnosis of prostate adenocarcinoma, underwent MRI examination before and after local RT for the assessment of response to treatment. Apparent diffusion coefficient (ADC) values were calculated and compared. Results: Before RT, DWI shows pathologic restriction of signal, while after RT pathologic restriction of signal was reduced or disappeared. The ADC values were significantly increased after therapy (p<0.05). Conclusions: The use of DWI with ADC measurements may be an imaging biomarker in the assessment of prostate cancer.
2016
apparent diffusion coefficient; diffusion-weighed imaging; magnetic resonance imaging; prostate cancer; response to therapy; adenocarcinoma; aged; aged, 80 and over; biomarkers, tumor; feasibility studies; humans; male; neoplasm grading; prospective studies; prostate-specific antigen; prostatic neoplasms; reproducibility of results; sample size; treatment outcome; diffusion magnetic resonance imaging
01 Pubblicazione su rivista::01a Articolo in rivista
Diffusion-weighted magnetic resonance imaging in patients with prostate cancer treated with radiotherapy / Iannelli, G.; Caivano, R.; Rago, L.; Simeon, V.; Lotumolo, A.; Rabasco, P.; Villonio, A.; Gioioso, M.; Mastrangelo, P.; Barchetti, F.; Panebianco, V.; Macarini, L.; Guglielmi, G.; Cammarota, A.. - In: TUMORI. - ISSN 0300-8916. - 102:1(2016), pp. 71-76. [10.5301/tj.5000415]
File allegati a questo prodotto
File Dimensione Formato  
Iannelli_Diffusion-weighted magnetic_2016.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 276.42 kB
Formato Unknown
276.42 kB Unknown   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1315702
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact